Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination

Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination

SARS-CoV-2 has gradually acquired amino acid substitutions in its S protein that reduce the potency of neutralizing antibodies, leading to decreased vaccine efficacy. Here, we attempted to obtain mutant viruses by passaging SARS-CoV-2 in the presence of plasma samples from convalescent patients or v...

Detaylı Bibliyografya
Asıl Yazarlar:	Yamamoto, S, Yamayoshi, S, Ito, M, Sakai-Tagawa, Y, Nakachi, I, Baba, R, Kamimoto, S, Ogura, T, Hagiwara, S, Kato, H, Nakajima, H, Uwamino, Y, Yagi, K, Sugaya, N, Nagai, H, Saito, M, Adachi, E, Koga, M, Tsutsumi, T, Duong, C, Okuda, M, Murakami, J, Furusawa, Y, Ujie, M, Iwatsuki-Horimoto, K, Yotsuyanagi, H, Kawaoka, Y
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Cell Press 2023

Benzer Materyaller

Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
Yazar:: Shinya Yamamoto, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Correlation analysis between gut microbiota alterations and the cytokine response in patients with coronavirus disease during hospitalization
Yazar:: Mizutani, T, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
Yazar:: Uraki, R, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV
Yazar:: Aya Ishizaka, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
Yazar:: Yamayoshi, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Dysbiosis of gut microbiota in COVID-19 is associated with intestinal DNA phage dynamics of lysogenic and lytic infection
Yazar:: Aya Ishizaka, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination
Yazar:: Aya Ishizaka, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Comparison of Rapid Antigen Tests for COVID-19
Yazar:: Seiya Yamayoshi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization
Yazar:: Taketoshi Mizutani, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Sensitivity of rodents to SARS-CoV-2: Gerbils are susceptible to SARS-CoV-2, but guinea pigs are not
Yazar:: Kiyoko Iwatsuki-Horimoto, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Incidence of sexually transmitted hepatitis C virus infection among men who have sex with men in Japan from 2009 to 2023
Yazar:: Adachi, E, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate
Yazar:: Ryuta Uraki, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
Yazar:: Ryuta Uraki, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018–2019 and 2019–2020 Influenza Seasons in Japan
Yazar:: Takuma Soga, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Subclade 2.2.1-Specific Human Monoclonal Antibodies That Recognize an Epitope in Antigenic Site A of Influenza A(H5) Virus HA Detected between 2015 and 2018
Yazar:: Moe Okuda, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01)

An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters
Yazar:: Ryuta Uraki, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018–2019 Influenza Season
Yazar:: Yuko Sakai-Tagawa, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Transmission and re-infection of Omicron variant XBB.1.5 in hamstersResearch in context
Yazar:: Peter J. Halfmann, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
Yazar:: Seiya Yamayoshi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases
Yazar:: Atsuhiro Yasuhara, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2
Yazar:: Hiroshi Ueki, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Cardiomyopathy Does Not Exacerbate the Severity of Pneumonia Caused by a SARS-CoV-2 Delta Variant in the J2N-k Hamster Model
Yazar:: Kiyoko Iwatsuki-Horimoto, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Isolation and Characterization of Human Monoclonal Antibodies That Recognize the Influenza A(H1N1)pdm09 Virus Hemagglutinin Receptor-Binding Site and Rarely Yield Escape Mutant Viruses
Yazar:: Atsuhiro Yasuhara, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020–March 2022
Yazar:: Seiya Yamayoshi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan
Yazar:: Seiya Yamayoshi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo
Yazar:: Ryuta Uraki, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Treatment of Highly Pathogenic H7N9 Virus-Infected Mice with Baloxavir Marboxil
Yazar:: Maki Kiso, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01)

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
Yazar:: Yuko Sakai-Tagawa, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants
Yazar:: Ryuta Uraki, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Development of an Influenza Rapid Diagnostic Kit Specific for the H7 Subtype
Yazar:: Kiyoko Iwatsuki-Horimoto, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Antigenic Change in Human Influenza A(H2N2) Viruses Detected by Using Human Plasma from Aged and Younger Adult Individuals
Yazar:: Yukimasa Matsuzawa, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir
Yazar:: Maki Kiso, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
Yazar:: Peter J. Halfmann, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols
Yazar:: Hiroshi Ueki, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Measurement of activation of helium gas by 238U beam irradiation at about 11 A MeV
Yazar:: Akashio A., ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

An mRNA vaccine candidate encoding H5HA clade 2.3.4.4b protects mice from clade 2.3.2.1a virus infection
Yazar:: Shiho Chiba, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

A METHOD FOR RECOGNIZING RAINFALL-SENSITIVE URBAN ROADS BASED ON TRAJECTORY DATA
Yazar:: S. Zhu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Strain-Specific Contribution of Eukaryotic Elongation Factor 1 Gamma to the Translation of Influenza A Virus Proteins
Yazar:: Shuhei Sammaibashi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Identification of Amino Acid Residues in Influenza A Virus PA-X That Contribute to Enhanced Shutoff Activity
Yazar:: Kohei Oishi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

Role of Microbiota in Viral Infections and Pathological Progression
Yazar:: Taketoshi Mizutani, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)